Fig. 5

Enzyme-Linked Immunosorbent Assay (ELISA) in cord blood and maternal peripheral blood in FTB and PTB. a Graphic displaying IL-17 plasmatic concentrations in cord blood FTB (n = 15) and PTB (n = 5), as well as, plasmatic concentrations of IL-17 in maternal Peripheral Blood (PB) (n = 6). b Graphic displaying IL-22 plasmatic concentrations in cord blood FTB (n = 15) and PTB (n = 6), as well as, plasmatic concentrations of IL-22 in maternal Peripheral Blood (PB) (n = 6). c Graphic displaying Ifn-γ plasmatic concentrations in cord blood FTB (n = 15) and PTB (n = 6), as well as, plasmatic concentrations of Ifn-γ in maternal Peripheral Blood (PB). d Graphic displaying IL-4 plasmatic concentrations in cord blood FTB (n = 15) and PTB (n = 6), as well as, plasmatic concentrations of IL-4 in maternal Peripheral Blood (PB). Student’s t-tests were used for statistical analysis with a 95% confidence interval. A statistical significant decrease in Ifn-γ plasma concentration was found, in peripheral blood samples in women with PTB